DoW Multiple Sclerosis Clinical Trial Award

Dept. of the Army -- USAMRAA

Published: May 5, 2026

Updated: Jun 20, 2026

Source: grants_gov

About This Opportunity

DoW Multiple Sclerosis Clinical Trial Award — grant funding tender in United States, Dept. Submission deadline Aug 2026.

This is a grants contract in the information and communication technology sector. Located in United States, North America, this opportunity is open to firms and consortiums. Proposals must be submitted before August 13, 2026.

Published through Grants.gov, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for grants in the information and communication technology sector. Grant applications generally require a detailed project proposal, a clear results framework, and evidence of the applicant's capacity to deliver the proposed activities. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Summary: The fiscal year 2026 (FY26) Multiple Sclerosis Research Program (MSRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of multiple sclerosis. All applications must address at least one of the FY26 MSRP CTA focus areas. Clinical trials may evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technologies.
Distinctive Features: The FY26 CTA offers two funding levels. The following are generalized descriptions of the scope of research appropriate for each funding level:
• Funding Level 1 (CTA-FL1) supports small-scale, proof-of-principle clinical trials (e.g., pilot, first-in-human, phase 0) to demonstrate feasibility or inform the design of more advanced trials, or other clinical trials that are appropriate for this funding level. Preliminary data relevant to the proposed clinical trial are required.
• Funding Level 2 (CTA-FL2) supports larger-scale clinical trials at phase 1 or phase 2 that seek to show preliminary evidence of safety or efficacy (i.e., benefit of clinical or paraclinical outcomes) in relevant patient populations. Clear description and justification should be provided, which could include, but is not limited to, the intervention type, trial duration, sample size, outcome measures, assessment tools and frequency of assessment. Preliminary data relevant to the proposed clinical trial in MS populations are required.
For the purposes of this funding opportunity, Regulatory Agency refers to the U.S. Food and Drug Administration (FDA) or any relevant international regulatory agency unless otherwise noted.

Agency: JoAnn Martin
Grantor

CFDA: 12.420

Applicant Types: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Cost Sharing: No

Contact: JoAnn Martin
Grantor

Email: help@eBRAP.org

Data provenance

This notice is sourced from Grants.gov and was originally published on May 5, 2026. Last refreshed 5 days ago. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Dept. of the Army -- USAMRAA

Dept. of the Army -- USAMRAA has issued 77 procurement notices on BidsFactory, including 77 currently open and 0 awarded contracts. Activity concentrates in Health & Medical, Research & Innovation, and Information & Communication Technology. All notices are published for United States. Notices are distributed via Grants.gov. Most recent publication: June 17, 2026.

Frequently asked questions about this tender

What type of contract is this?

This is a Grants contract in the Information & Communication Technology sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in United States. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit Grants.gov to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is August 13, 2026. You have 49 days left to prepare and submit your proposal to the contracting authority.

Who is the contracting authority?

This notice was issued by Dept. of the Army -- USAMRAA in United States. The authority is responsible for evaluating bids, awarding the contract, and managing performance.